Equity Details
Price & Market Data
Price: $2.18
Daily Change: $0.00 / 0.00%
Daily Range: $2.07 - $2.31
Market Cap: $261,633,824
Daily Volume: 2,130,083
Performance Metrics
1 Week: -4.66%
1 Month: 71.76%
3 Months: 106.4%
6 Months: 110.3%
1 Year: 110.3%
YTD: 129.0%
About Fate Therapeutics, Inc. (FATE)
Stay informed with Fate Therapeutics, Inc. (FATE) market data. Current price: 2.18, daily change: $0.00 / 0.00%. Market cap: 261,633,824. Performance over 1-month, 3-month, and 1-year.
Company Details
Employees: 161
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.